During the past decade, Hôpital Privé des Côtes d'Armor conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé des Côtes d'Armor" #1 sponsor was "UNICANCER" with 3 trials, followed by "BeiGene" with 2 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored, "Centre Oscar Lambret" with 1 trials sponsored and "Clovis Oncology, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé des Côtes d'Armor" #1 collaborator was "National Cancer Institute, France" with 2 trials as a collaborator, "Accord Healthcare, Inc." with 1 trials as a collaborator, "Aix Marseille Université" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Belgian Group of Digestive Oncology" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé des Côtes d'Armor" are "Advanced or Inoperable Gastric Cancer" (1 trials), "Aging" (1 trials), "BPH" (1 trials), "Biliary Tract Neoplasms" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Hôpital Privé des Côtes d'Armor" in a lesser frequency.

Most popular intervention types in "Hôpital Privé des Côtes d'Armor" are "Drug" (8 trials), "Device" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Cisplatin" (2 trials), "5-Fluoro-uracil" (1 trials), "Binimetinib" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé des Côtes d'Armor" are 9 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Privé des Côtes d'Armor". 1 are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hôpital Privé des Côtes d'Armor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé des Côtes d'Armor, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".